Last reviewed · How we verify
NCT05849844
Tympanoseal Clinical Study
NA trial testing Tympanoseal in Tympanic Membrane Perforation in 45 participants. Currently enrolling.
20 April 2026
Quick facts
| Lead sponsor | Grace Medical, Inc. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 5 January 2024 |
| Primary completion | 20 April 2026 |
| Estimated completion | 20 April 2026 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Tympanoseal
Conditions studied
- Tympanic Membrane Perforation — all drugs for Tympanic Membrane Perforation →
Sponsor
Grace Medical, Inc.
Who can join
Adults 2 to 100, any sex, with Tympanic Membrane Perforation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05849844
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Tympanoseal
Trials testing the same drug.
- NCT02918942 — Tympanoseal (Tympanic Membrane Device) Clinical Study · completed
Other recruiting trials for Tympanic Membrane Perforation
Currently open trials in the same condition.
- NCT06260618 — Effect of Chitodex Gel in Tympanoplasty Surgery · NA · recruiting
Other Grace Medical, Inc. trials
Trials by the same sponsor.
- NCT02918942 — Tympanoseal (Tympanic Membrane Device) Clinical Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05849844 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Grace Medical, Inc.
- Last refreshed: 15 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05849844.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing